Dr. Lui Franciosi, PhD

Dr. Lui Franciosi, PhD

Chief Executive Officer

Dr. Franciosi has more than 20 years of experience conducting pharmaceutical and medical device studies in academia and industry. Previously, he acted as the Chief Operating Officer at Verona Pharma PLC, London Stock Exchange (AIM: VRP). Prior to Verona Pharma, Dr. Franciosi completed his post-doctoral research in COPD progression modeling at the Clinical Pharmacology & Discovery Medicine Unit, GlaxoSmithKline, UK. He obtained his Doctorate & Masters degrees at The University of British Columbia (UBC), Canada – and pursued business studies at the University of Warwick, UK. He is currently an adjunct professor at UBC Faculty of Medicine, Department of Anesthesiology, Pharmacology & Therapeutics.

Peter McFadden CPA, CA, TEP, MBA, HB. Comm, BSc

Peter McFadden CPA, CA, TEP, MBA, HB. Comm, BSc

Interim Chief Financial Officer

Mr. McFadden is an experienced accounting and finance professional and holds numerous professional designations. He is currently a partner at McFadden, Buttar & Associates CPAs Inc. He was formerly a senior manager at KPMG specializing in mergers and acquisitions and tax in Toronto.  He has also taught Business and Accounting courses at the Okanagan University College.

Mr. McFadden holds a bachelor of Science from McMaster University, a bachelor of Commerce with honors from University of Windsor, and became a Chartered Accountant (CA) in 1983. Additionally he obtained his Masters in Business Administration (MBA) in International Finance and Accounting in 1981.

We have the skillset and the abilities to potentially substantiate claims surrounding marijuana for medicinal use. Not only from a scientific, but an intellectual property point of view, protecting our research and discovery in this exciting space.

Dr. Lui Franciosi


Dr. Scott Alexander, MBBS

Dr. Scott Alexander, MBBS

Medical Director

Dr. Alexander completed his medical degree at the University of Queensland in Brisbane, Australia. He earned his undergraduate and Masters degrees at Simon Fraser University in Burnaby, Canada. His Master’s thesis in neuroscience focused motor deficits in older adults with age-related macular degeneration. His research led to recommendations to civil engineers in designing enhanced environments for people with low-vision. Dr. Alexander’s undergraduate honour’s thesis was in behavioural neuroscience. He examined how perceptual shifts in visual input altered motor maps in the brain through the posterior parietal cortex, leading to long-term adaptations. This research has shown to help improve motor functions in individuals who have suffered debilitating strokes. During medical school, Dr. Alexander led two significant research projects. 1) A study in knowledge translation in the early detection and prevention of dementia. He coordinated Family Physician focus groups and extracted qualitative data from their conversations to drive practical research in dementia. 2) He validated a frailty assessment tool for rehabilitation inpatients, which monitored patient progress on a daily basis while in hospital.

The Veritas Newsletter

Enter your email to receive news alerts and updates from Veritas Pharma.

You have Successfully Subscribed!